Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Poznan, Poland.
Student Scientific Society, Department of Pharmacoeconomics and Social Pharmacy, Poznan University of Medical Sciences, Poznan, Poland.
PLoS One. 2022 Oct 13;17(10):e0275272. doi: 10.1371/journal.pone.0275272. eCollection 2022.
Over the last decade, we've observed an enormous social media development, which have recently become commercial services. Hence, we aimed to verify if Facebook might be considered as a source of access to medicines. We also intended to identify prescription (Rx) and over the counter (OTC) medicines if available on that platform. The study was conducted from January 2019 to July 2020. We investigated offers of pharmaceuticals posted on Facebook (individual posts and communities) between 2016 and 2019. Medicines were divided into Rx and OTC brands and in accordance with their possible therapeutic use. We verified whether the medicines were for sale, to exchange, or available for free. Posts and groups were investigated for example, by entering the phrase "for free," followed by a city in Poland. Out of 409 offers, 380 (92.91%) concerned Rx brands and 29 (7.09%) OTC brands. 315 (77.02%) medications were available "for free". In 47 (11.49%) cases, an "exchange" was expected, and 47 (11.49%) announcements were marked as "for sale". Cardiovascular medicines (n = 125; 30.56%) were the most popular. There were also antidiabetics (n = 38; 9.29%) and antipsychotics (n = 28; 6.84%). We also found clear candidates for misuse. These were opioids (n = 7; 1.71%), benzodiazepines (n = 2; 0.48%), clomifene (n = 1; 0.24%), and letrozole (n = 1; 0.24%). Facebook provides the possibility of uncontrolled access to medicines. The majority of offers concerned Rx brands, including opioids and benzodiazepines. Medicines offered on Facebook were mainly accessible for free. The scope and the number of medications offered on Facebook should make this issue a hazardous phenomenon.
在过去的十年中,我们观察到社交媒体的巨大发展,这些社交媒体最近已成为商业服务。因此,我们旨在验证 Facebook 是否可以被视为获取药物的来源。我们还试图确定该平台上是否提供处方 (Rx) 和非处方 (OTC) 药物。这项研究于 2019 年 1 月至 2020 年 7 月进行。我们调查了 2016 年至 2019 年期间 Facebook 上发布的药品广告(个人广告和社区)。药品分为 Rx 和 OTC 品牌,并根据其可能的治疗用途进行分类。我们验证了药品是否可供销售、交换或免费提供。例如,我们通过输入“免费”一词,并加上波兰的一个城市,来调查帖子和群组。在 409 条广告中,380 条(92.91%)涉及 Rx 品牌,29 条(7.09%)涉及 OTC 品牌。315 种(77.02%)药物可免费提供。在 47 个(11.49%)情况下,预计进行“交换”,而 47 个(11.49%)广告被标记为“出售”。心血管药物(n = 125;30.56%)最受欢迎。还有抗糖尿病药物(n = 38;9.29%)和抗精神病药物(n = 28;6.84%)。我们还发现了明显的滥用药物。这些是阿片类药物(n = 7;1.71%)、苯二氮䓬类药物(n = 2;0.48%)、氯米芬(n = 1;0.24%)和来曲唑(n = 1;0.24%)。Facebook 提供了不受控制获取药物的可能性。大多数广告涉及 Rx 品牌,包括阿片类药物和苯二氮䓬类药物。在 Facebook 上提供的药物主要免费提供。Facebook 上提供的药物的范围和数量使得这一问题成为一个危险的现象。